Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Bone Marrow Mononuclear Cell Infusion With Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus

NCT00767260 is registered in ClinicalTrials.gov with Fuzhou General Hospital as lead sponsor.

NCT NCT00767260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00767260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Bone Marrow Mononuclear Cell Infusion With Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus
Lead sponsor
Fuzhou General Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2008
Completion date
March 31, 2015
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus